According to the Center for Disease Control, severe joint issues afflict over 14.6 million people throughout the United States. The most common issue effecting joints is the onset of arthritis and one of the most regularly afflicted areas are the knees. With about one million knee and hip joint replacements occurring each year (99% of those due to arthritis-related pain), patients are seeking less invasive forms of therapy. The number of cases of arthritis-related knee pain is expected to rise in the coming years, and new forms of treatment, such as those we offer at CELLAXYS, are beginning to see an upsurge in interest.
Specifically, knee-related arthritis falls into the category of Osteoarthritis (OA). Contrary to popular belief, this is not just an age-related disease and can affect anyone who injures or overuses their joints. Athletes, labor-intensive workers, and obese people are especially susceptible to developing symptoms at an early age. While there is no cure for OA, there are several options for treatment with varying degrees of success.
Some doctors prescribe anti-inflammatory medications or periodic steroid injections for knee-related issues. Others administer what are called hyaluronic acid injections aimed at providing temporary lubrication to the knee or endorse physical therapy, weight loss, assistive mobility devices, and heat and cold treatments to calm a patient’s issues.
While these treatments may reduce pain for a time, they are temporary and in most cases, ineffective.
This is not the case for the procedures offered at CELLAXYS. The Induced Pluripotent Stem (iPS) cell and Platelet Rich Plasma (PRP) therapies we offer help to resolve many kinds of knee issues. Some of the most common knee-related problems our treatments help to resolve are:
- Cartilage Defects / Thinning
- Ligament Partial-Tears (MCL, LCL, ACL, PCL)
- Patellar Tendonitis and Partial-Tears
And of course,
- Knee Osteoarthritis or Chronic Knee Pain After Surgery
When used in conjunction, iPS and PRP provide a new mechanism for your body to heal itself. The pluripotent stem cells provide source material for your body to develop into new tissue. The platelet rich plasma initiates and amplifies your body’s natural healing processes. Once injected, the PRP sends signals to your body which funnel blood and nutrients to the affected area. The injection site slowly floods with fibrin, collagen and elastin which, acting with the pluripotent stem cells, regenerate tissues which were lost over the years of extensive use. In the end, these treatments enable patients to have greater mobility, reduced pain, and a more functional joint than traditional therapies.
Another chief benefit of iPS and PRP therapies is that their source material comes directly from the patient’s own body. This ensures that the body will not reject the incoming cells and dismisses any rejection-related issues which may be present in traditional therapies. Additionally, iPS and PRP tend to be the longest lasting injection therapies known so far. Once injected, the cells will continue to improve mobility and range for up to 12 months and sustain these improvements for a much longer period that similar therapies.
If you would like to learn more about the benefits and science behind iPS and PRP therapies, call CELLAXYS today for a consultation.